Direct Oral Anticoagulants in Patients With VTE and Cancer

Maria Cristina Vedovati; Federico Germini; Giancarlo Agnelli; Cecilia Becattini

doi:10.1378/chest.14-0402

Related publications

Letter2019

Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer

Giancarlo Agnelli

Article2019

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

So-Ryoung Lee, Hyun‐Jung Lee, Eue-Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2020

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

Yi‐Hsin Chan, Lung‐Sheng Wu, Lai‐Chu See, Jia‐Rou Liu, Shang‐Hung Chang, Tze‐Fan Chao, Yung‐Hsin Yeh, Chi‐Tai Kuo, Hsin‐Fu Lee, Professor Gregory Lip

Article2023

Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia

Nour R. Al‐Hussainy, Kristian Kragholm, Søren Lundbye‐Christensen, Christian Torp‐Pedersen, Manan Pareek, Susette Krohn Therkelsen, Professor Gregory Lip, Sam Riahi

Article2017

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants

Jessica Dennis, Jessica Dennis, Alejandra Medina-Rivera, Alejandra Medina-Rivera, Vinh Trương, Vinh Trương, Lina Antounians, Lina Antounians, Nora Zwingerman, Nora Zwingerman, Giovana Carrasco, Giovana Carrasco, Lisa Strug, Lisa Strug, Philip S. Wells, Philip S. Wells, France Trégouët, France Trégouët, France Morange, France Morange, Michael Wilson, Michael Wilson, France Gagnon, France Gagnon, Pierre Albaladejo,